We spoke with 16 C-level executives from UK-based biotechs about recent US policies (such as MFN pricing) & the likely impact on the UK biotech sector.

Biotech innovation doesn’t slow down—and neither should your lab partner. This brief outlines how early scientific engagement, operational transparency, and integrated global lab services help reduce risk, stay on schedule, and deliver results. Whether you're navigating your first trial or scaling a growing pipeline, see how a purpose-built lab model can help you move smarter and faster.

Learn how to streamline ePI compliance with AI-powered tools and meet global mandates—essential insights for regulatory and content leaders. Download this whitepaper today.

Learn how natural language processing (NLP) unlocks critical insights from unstructured EHR data—like physician notes and patient narratives—to give researchers a complete view of the patient journey. See how combining structured and unstructured data advances drug development. Download now.

With 30+ years’ experience, Sciensus helps biopharma navigate Europe’s healthcare complexity to bring therapies to patients. From early access and decentralised trial support to real-world evidence and in-home care, we provide the infrastructure and insight to accelerate access and unlock commercial value. Meet the Sciensus team at BIO to discuss how we can support your European strategy. Learn more.

In Puerto Rico, companies tap into decades of experience in scientific innovation, business-friendly incentives and public-private partnerships to push new frontiers of medicine. Join a dynamic ecosystem on the cutting-edge of biotech production and R&D.